using a thermistor-tipped catheter. The CO is calculated using an algorithm based on the area under the systolic part of the pressure waveform after calibration by transpulmonary thermodilution. 7 This calibration is also used to adjust for individual vascular compliance. The system has extensively been evaluated and most studies demonstrate adequate results using the current device and software when compared with pulmonary artery thermodilution. 8 -11 Recently, a new pulse wave analysis device that does not require external calibration has become available. 12 The FloTrac/Vigileo TM system (Edwards Lifesciences, Irvine, CA, USA) obtains the pressure wave signal from any standard peripheral arterial line and the SD of pulse pressure is empirically correlated to the stroke volume (SV) based on patient characteristics (age, gender, body height, and weight) after automatic adjustment for actual vascular compliance. Early validation studies for this device showed conflicting results. 12 -15 As a consequence, the FloTrac/Vigileo TM software with its underlying algorithm was improved and the time window for vascular adjustment was reduced.
The aim of this study was to evaluate the accuracy of CO measurements in patients undergoing elective cardiac surgery; the CO was determined using four devices: (1) the FloTrac/Vigileo TM system with upgraded software (FCO), (2) the PiCCOplus TM system (PCO), (3) continuous CO monitoring using a PAC (CCO, in combination with a Vigilance TM monitor, Edwards Lifesciences), and (4) intermittent pulmonary artery thermodilution.
Methods

Patients and setting
Patients undergoing elective coronary artery bypass grafting and/or valve surgery gave their informed consent to the study, which was approved by the local Ethics Committee. Exclusion criteria were reduced left and right ventricular function (ejection fraction ,40%), preoperative dysrhythmias, severe valve regurgitation, intracardiac shunts, pulmonary artery hypertension, severe arterial occlusive disease, and body weight ,40 kg. A sample size of 25 patients was calculated on the basis of an expected difference of mean values between CO determination by the continuous measurement techniques and intermittent thermodilution of 0.3 litre min 21 (a = 0.05 and power .0.9).
Routine perioperative management
Anaesthesia and postoperative management followed institutional standards. After tracheal intubation, the lungs were ventilated using volume-controlled mode to maintain normocarbia. In the postoperative period, the patients were extubated in the intensive care unit after the completion of the institutional weaning protocol. 
CO monitoring
After induction of anaesthesia, a 7.5 F PAC (Swan-Ganz CCO/VIP PAC, Edwards Lifesciences) was introduced via right internal jugular vein access and attached to a Vigilance TM monitor (Version 6.3, Edwards Lifesciences). A CO monitoring set with a closed cold injectate delivery system (Edwards Lifesciences) used for intermittent thermodilution was connected to the proximal lumen of the PAC.
A 4F thermistor-tipped arterial catheter (Pulsiocath TM thermodilution catheter) was inserted into the left femoral artery, its tip advanced to the abdominal aorta, and connected to the stand-alone PiCCOplus TM computer (Version 6.0; Pulsion Medical Systems). Continuous CO measurement was initiated after the initial calibration of the system by a triplicate 20 ml ice-cold normal saline injection through an additional 7F central venous catheter (transpulmonary thermodilution). The calibration process was repeated according to the manufacturer's guidelines every 8 h.
A FloTrac TM sensor kit was connected to the arterial line and connected to the Vigileo TM monitor programmed with the 1.07 version of the software for this device (Edwards Lifesciences). Patient data (age, gender, body weight, and height) were entered and after checking the arterial line waveform fidelity, the system was zeroed and CO measurement initiated. The CO was recorded continuously for 24 h except for a short period when the patient was transferred from the operating room into the intensive care unit.
Pulse wave analysis algorithms
FloTrac/Vigileo TM system The algorithm uses the basic equation (1) for measuring CO with heart rate (HR) being determined from the pressure waveform through conventional methods:
The calculation of SV can be divided into two parts based on manually entered patient data (age, gender, body length, and weight):
(1) The contribution of pulse pressure to SV, which is proportional to the SD of arterial pulse pressure (SD ap ).
(2) The influence of vascular resistance and compliance on SV integrated into a single variable (x). Thus, CO is calculated as follows (2):
Different characteristics of the blood pressure 16 are utilized in equation (3) for the derivation of x from a multivariate regression model (M). These include Langewouter's aortic compliance (Cp), 17 MAP, the variance, skewness, and kurtosis of the pressure wave curve. Body surface area (BSA) also appears in the model. Further details of this proprietary algorithm are not disclosed by Edwards Lifesciences.
x ¼ MðCp; MAP; variance; skewness; kurtosis; BSAÞ: ð3Þ
Pulse pressure is recorded at a frequency of 100 Hz and SD ap is determined during a window of 20 s. After the early clinical experiences with this algorithm, the rate of the adjustment of x was reduced from the initial interval of 10 to 1 min in the latest version of the software.
PiCCOplus
TM system The basics of the PiCCOplus TM method and its underlying algorithm have been described in detail elsewhere. 7 Briefly, CO is calculated every 3 s by measuring the area under the systolic part of the arterial pressure waveform and dividing this area by the aortic impedance. 18 For an adjustment of individual aortic compliance, calibration by transpulmonary thermodilution is required. Modification of the algorithm enhanced accuracy by the additional analysis of the shape of the pressure waveform. 10 
Study protocol
The CO data from all devices and standard haemodynamic data (HR, MAP, central venous pressure, and PCWP) were recorded by an observer not involved in the routine management of the patient at predefined time points before transpulmonary thermodilution measurements. Transpulmonary thermodilution measurements were made under stable haemodynamic conditions. Three injections of iced NaCl 0.9% (10 ml, 4 -68C) were made using a closed cold injectate delivery system and the mean value recorded. The measurements were free of interference from surgery or infusion boluses. Predefined measurement points were: T1¼after induction of anaesthesia (study initiation), T2 ¼1 h post-initiation (after sternotomy), T3¼4 h postinitiation (at skin closure), T4-6¼8, 12, and 24 h postinitiation (after the transfer to the intensive care unit). The mean duration of mild hypothermic cardiopulmonary bypass was 100(11) min, mean operation time was 261(48) min, and mean ICU stay was 2(1) days. The measurement period was uneventful for all patients. After the removal of the PiCCO catheter, one patient (3%) developed arterial bleeding resulting in an inguino-scrotal haematoma requiring surgical intervention.
Statistics
There was a significant increase in HR and CO assessed by all tested techniques during the observation period (Table 1) . Systemic vascular resistance significantly decreased, whereas all other haemodynamic variables (MAP, MPAP, CVP, and PCWP) showed no significant changes over time.
CO assessed by the FloTrac/Vigileo TM and the PiCCOplus TM system was significantly higher for the first two measurements when compared with CO assessed by intermittent thermodilution. The CO values ranged between 2.4 and 7.5 litre min 21 during the intraoperative period and between 3.1 and 9.3 litre min 21 in the postoperative period. Bland -Altman analysis (Figures 1 and 2 , Table 2 ) revealed a consistently positive mean bias for the FloTrac/ Vigileo TM system, the PiCCOplus TM system, and continuous CO monitoring by the PAC when compared with the intermittent pulmonary artery thermodilution at every measurement point during the intraoperative and the postoperative observation period. This finding indicates an overestimation of CO by all continuous measurement techniques. Agreement for all devices decreased early after the intervention (T3 -4).
Discussion
In the present study, we tested a new pulse wave analysis device and two established systems for continuous CO system are based on pulse pressure analysis. They calculate the flow from the arterial pressure waveform, which is itself the result of an interaction between the SV and the elastic properties of the systemic vascular system. Thus, resistance, compliance, and impedance at the site of the signal detection must be considered. The FloTrac/ Vigileo TM system calculates CO by the analysis of the impact of vascular tone on pressure and adjustment for actual vascular tone based on waveform analysis and patient characteristics. In contrast to other available pulse contour techniques, 10 20 the system does not require an external reference method for calibration or subsequent correction. Therefore, it minimizes operator dependency and its automatic adjustment for the changes of vascular tone may eliminate drift phenomena.
Recently published studies investigating the FloTrac/ Vigileo TM system showed inconsistent results. . 13 In our study, in contrast, better results for the FloTrac/Vigileo TM system were found in terms of a smaller bias or smaller limits of agreement for all measurements. These findings may be explained by the fact that the software has been modified recently. In order to better reflect the actual vascular status of the patient, the time window for vascular adjustment has been reduced from 10 to 1 min. Therefore, haemodynamic changes before the measurement periods-even under conditions of haemodynamic stability (i.e. after sternotomy)-may have had a larger impact on measurements in the studies performed by Sander and colleagues 15 or Mayer and colleagues. 13 Overall bias and limits of agreement for the PiCCOplus TM system obtained in this study correspond to the data of previously published work. 8 -11 In contrast to the FloTrac/Vigileo TM system, this system uses transpulmonary thermodilution for calibration. Inaccurate measurements as a result of variations in systemic vascular resistance were observed when the initial algorithm was used. 21 However, after the modification of the algorithm to better address the individual patient's aortic compliance, the majority of studies found a good agreement between the PiCCOplus TM values and the intermittent thermodilution. 8 10 11 The modified algorithm also appears to be more robust in the situations of haemodynamic changes. 9 Interestingly, recent studies evaluating this system in cardiac surgery patients revealed reliable measurements before cardiopulmonary bypass, but less accurate results if no recalibration was performed early after cardiopulmonary bypass. 22 23 In this period of surgery, temperature and fluid shifts and changes of vascular tone occur, 24 and early recalibration has been suggested to improve performance. 23 Despite the early recalibration in our study, we still observed a decreased agreement between the PiCCOplus TM system and the reference method in the postoperative period. This finding may be related to an increase in signal-to-noise ratio of Table 1 Haemodynamics during the study period. T1¼after induction of anaesthesia, T2¼after sternotomy, T3¼at skin closure, T4¼after transfer to the ICU, T5 -6¼during ICU stay hours 12 and 24 after study initiation. HR, heart rate; MAP, mean arterial pressure; MPAP, mean pulmonary artery pressure; CVP, central venous pressure; PCWP, pulmonary capillary wedge pressure; SVR, systemic vascular resistance; CO, cardiac output; FCO, CO assessed by the FloTrac/ Vigileo TM device; PCO, CO assessed by the PiCCOplus TM system; CCO, continuous CO measured by PAC using the Vigilance TM monitoring; ICO, CO determined by the intermittent pulmonary artery thermodilution. Data are presented as mean(SD). *P,0.05 compared with ICO, **P,0.05 compared with T1, ***P,0.05 compared with T2 (all comparisons with T3 and T4 not significant)
Intraoperative measurements
Postoperative measurements   T1  T2  T3  T4  T5 64 (16) 67 (16) 82 (12)**/*** 89 (7)**/*** 88 (11)**/*** 77 (12)**/*** MAP (mm Hg) 76 (12) 74 (11) 72 (7) 72 (8) 72 (8) 77 (9) MPAP (mm Hg)
25 (9) 24 (10) 24 (7) 24 (6) 24 (6) 24 (6) CVP (mm Hg) 12 (4) 10 (4) 12 (3) 11 (4) 11 (4) 12 (4) PCWP (mm Hg)
16 (6) 16 (4) 16 (4) 15 (5) 15 (5) 16 (12) 25 One of our patients enrolled in this study had a major bleeding complication requiring surgical intervention after removal of the PiCCO TM catheter. Despite the development and the increased clinical use of different less invasive devices in the last years, continuous CO monitoring using the PAC remains the standard, especially when monitoring of pulmonary artery pressures is indicated. Corresponding to previous investigations, 22 26 Fig 1 Bland -Altman analysis for CO measurements during the intraoperative period using the FloTrac/Vigileo TM system, the PiCCOplus TM system, and the PAC/Vigilance TM monitoring compared with the intermittent pulmonary artery thermodilution. T1¼after induction of anaesthesia, T2¼after sternotomy, T3¼at skin closure; CO, cardiac output; FCO, CO by the FloTrac/Vigileo TM device; PCO, CO by the PiCCOplus TM system; CCO, continuous CO measured by PAC using the Vigilance TM monitoring; ICO, CO by intermittent pulmonary artery thermodilution (iced water bolus method). Solid line, mean bias; dashed lines, limits of agreement.
Clinical evaluation of the FloTrac/Vigileo TM system for cardiac output measurement we found a closer agreement between continuous CO monitoring and intermittent thermodilution in the preintervention period than in the early postoperative period. However, these changes of accuracy were less distinct than that reported previously. Some limitations and methodological aspects have to be considered. The CO was assessed in low-risk cardiac surgical patients and values obtained were in a narrow range.
Although the study revealed a comparable performance of the continuous CO monitoring systems, large limits of agreement were observed indicating that all continuous monitoring systems studied have limitations as regards their reliability and accuracy. Intermittent pulmonary artery thermodilution was used as a reference method for CO measurement. This technique is often referred to as the clinical standard, but it has well-known pitfalls related to operator variation, patient pathologies, and the indicator used. 27 While operator influences were minimized and patient pathologies known to induce bias were excluded, thermal influences in the postoperative period are likely to have influenced our results. Techniques independent of thermal influence or flow measurements as additional reference methods would have been of interest in this situation. Finally, Bland-Altman analysis is a widely accepted method to compare two methods measuring the same variable. However, it has often been applied in a misleading manner. Initially designed to compare single measurements, 19 it is increasingly used to compare repeated measurements. In such situations, an incorrect assumption is made that measurements are independent. However, it may be used for repeated measurements to calculate separate values and draw separate figures for each time point.
In conclusion, the performance of all continuous CO measurement devices, i.e. the FloTrac/Vigileo TM and the PiCCOplus system TM , and continuous monitoring by PAC, was comparable in patients undergoing elective cardiac surgery. However, limitations regarding the reliability of all continuous cardiac techniques in this clinical situation should be borne in mind. 
